Eric M. Green West Pharmaceutical Services, Inc. President & CEO, Chair of the Board Bob W. McMahon Senior VP & Chief Financial Officer Fourth-Quarter and Full-Year 2025 Earnings Call February 12, 2026 | 8 a.m. Eastern Time To participate on the call by asking questions to Management, please register in advance by clicking here. A replay of the webcast will be available on the Company's website for on the call. approximately 90 days after the event. Registered telephone participants will receive the dial-in ...

(4)——0.50.01Other1.10.30.80.01Adjusted (Non-U.S. GAAP)$172.0$33.4$147.8$2.04Twelve Months ended December 31, 2025OperatingprofitIncometaxexpenseNetincomeDilutedEPSReported (U.S. GAAP)$584.9$121.6$493.7$6.79Unallocated items:Restructuring and other charges (1)23.30.922.40.31SmartDose® 3.5mL sale (2)8.41.96.50.09Cost-method investment activity (3)4.5—4.50.06Amortization of acquisition-related intangible assets (4)0.2—2.00.03Other1.10.30.80.01Adjusted (Non-U.S. GAAP)$622.4$124.7$529.9$7.29Three Months ended De ...